Number of the records: 1
Response of the Urothelial Carcinoma Cell Lines to Cisplatin
Title Response of the Urothelial Carcinoma Cell Lines to Cisplatin Author Holíčková Andrea SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Co-authors Roška Jan SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Órásová Eveline SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Bruderová Vladimíra SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Palacka Patrik Jurkovičová Dana 1973- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV ORCID Chovanec Miroslav 1969- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Source document International Journal of Molecular Sciences. Vol. 23, no. 20 (2022), art. no. 12488 Language eng - English Country CH - Switzerland Note open access URL URL link Document kind rozpis článkov z periodík (rzb) Citations STEELE, T.M. - TSAMOURI, M.M. - SIDDIQUI, S. - LUCCHESI, C.A. - VASILATIS, D. - MOOSO, B.A. - DURBIN-JOHNSON, B.P. - MA, A.H. - HEJAZI, N. - PARIKH, M. - MUDRYJ, M. - PAN, C.X. - GHOSH, P.M. Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer. In SCIENTIFIC REPORTS. ISSN 2045-2322, JUN 14 2023, vol. 13, no. 1. Dostupné na: https://doi.org/10.1038/s41598-023-36774-1. Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2022 Registered in WOS Registered in SCOPUS Registered in CCC DOI 10.3390/ijms232012488 article
File name Access Size Downloaded Type License Response of the Urothelial Carcinoma Cell Lines to Cisplatin.pdf available 1.3 MB 4 Publisher's version rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2022 2021 6.208 Q1 1.176 Q1
Number of the records: 1